BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 32287314)

  • 1. High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.
    Wang J; Ortiz C; Fontenot L; Xie Y; Ho W; Mattai SA; Shih DQ; Koon HW
    PLoS One; 2020; 15(4):e0231796. PubMed ID: 32287314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and Clinical Significance of Elafin in Inflammatory Bowel Disease.
    Zhang W; Teng G; Wu T; Tian Y; Wang H
    Inflamm Bowel Dis; 2017 Dec; 23(12):2134-2141. PubMed ID: 29084078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn's disease, and clinical prognosis in inflammatory bowel disease.
    Tran DH; Wang J; Ha C; Ho W; Mattai SA; Oikonomopoulos A; Weiss G; Lacey P; Cheng M; Shieh C; Mussatto CC; Ho S; Hommes D; Koon HW
    BMC Gastroenterol; 2017 May; 17(1):63. PubMed ID: 28494754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of elafin in peripheral blood in inflammatory bowel disease patients and its clinical significance].
    Zhang W; Teng GG; Tian Y; Wang HH
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(14):1120-3. PubMed ID: 27095781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: A prospective study in China.
    Chen JM; Liu T; Gao S; Tong XD; Deng FH; Nie B
    World J Gastroenterol; 2017 Dec; 23(46):8235-8247. PubMed ID: 29290660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-320a Monitors Intestinal Disease Activity in Patients With Inflammatory Bowel Disease.
    Cordes F; Demmig C; Bokemeyer A; Brückner M; Lenze F; Lenz P; Nowacki T; Tepasse P; Schmidt HH; Schmidt MA; Cichon C; Bettenworth D
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00134. PubMed ID: 32352717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2.
    Xie Y; Fontenot L; Chupina Estrada A; Nelson B; Wang J; Shih DQ; Ho W; Mattai SA; Rieder F; Jensen DD; Bunnett NW; Koon HW
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):841-876. PubMed ID: 35840034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history, diagnosis and treatment approach to fibrostenosing Crohn's disease.
    El Ouali S; Click B; Holubar SD; Rieder F
    United European Gastroenterol J; 2020 Apr; 8(3):263-270. PubMed ID: 32213020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
    Gathungu G; Kim MO; Ferguson JP; Sharma Y; Zhang W; Ng SM; Bonkowski E; Ning K; Simms LA; Croft AR; Stempak JM; Walker N; Huang N; Xiao Y; Silverberg MS; Trapnell B; Cho JH; Radford-Smith GL; Denson LA
    Inflamm Bowel Dis; 2013 Jul; 19(8):1671-80. PubMed ID: 23749272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease.
    Schmid M; Fellermann K; Fritz P; Wiedow O; Stange EF; Wehkamp J
    J Leukoc Biol; 2007 Apr; 81(4):907-15. PubMed ID: 17200145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease.
    Palmer NP; Silvester JA; Lee JJ; Beam AL; Fried I; Valtchinov VI; Rahimov F; Kong SW; Ghodoussipour S; Hood HC; Bousvaros A; Grand RJ; Kunkel LM; Kohane IS
    PLoS One; 2019; 14(10):e0222952. PubMed ID: 31618209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is ischemia modified albumin a disease activity marker for inflammatory bowel diseases?
    Kaplan M; Yuksel M; Ates I; Kilic ZM; Kilic H; Kuzu UB; Kayacetin E
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1120-5. PubMed ID: 26642816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.
    D'Haens G; Ferrante M; Vermeire S; Baert F; Noman M; Moortgat L; Geens P; Iwens D; Aerden I; Van Assche G; Van Olmen G; Rutgeerts P
    Inflamm Bowel Dis; 2012 Dec; 18(12):2218-24. PubMed ID: 22344983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATF4 Deficiency Promotes Intestinal Inflammation in Mice by Reducing Uptake of Glutamine and Expression of Antimicrobial Peptides.
    Hu X; Deng J; Yu T; Chen S; Ge Y; Zhou Z; Guo Y; Ying H; Zhai Q; Chen Y; Yuan F; Niu Y; Shu W; Chen H; Ma C; Liu Z; Guo F
    Gastroenterology; 2019 Mar; 156(4):1098-1111. PubMed ID: 30452920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
    Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
    Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum trefoil factor 3 predicts disease activity in patients with ulcerative colitis.
    Nakov R; Velikova T; Nakov V; Ianiro G; Gerova V; Tankova L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):788-794. PubMed ID: 30720187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
    Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
    J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell Composition in Ileal and Colonic Creeping Fat - Separating Ileal from Colonic Crohn's Disease.
    Kredel LI; Jödicke LJ; Scheffold A; Gröne J; Glauben R; Erben U; Kühl AA; Siegmund B
    J Crohns Colitis; 2019 Jan; 13(1):79-91. PubMed ID: 30272118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.